Anti-Covid vaccine: with Pfizer or Moderna, the risk of myocarditis remains overall "very rare" for the Medicines Safety Agency

Anti-Covid vaccine: with Pfizer or Moderna, the risk of myocarditis remains overall “very rare” for the Medicines Safety Agency

As part of the reinforced surveillance system for vaccines against Covid-19, the EPI-PHARE group has conducted a new pharmacoepidemiology study on the risk of myocarditis after injection of an mRNA vaccine from Pfizer laboratories (Comirnaty ) and from Moderna (Spikevax). According to new data relayed by the ANSM on July 22, 2022, the risk of …

Anti-Covid vaccine: with Pfizer or Moderna, the risk of myocarditis remains overall “very rare” for the Medicines Safety Agency Read More »